Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -.--% | -.--% | -.--% |
2020 | PAO Group, Inc. completed the acquisition of NCM Biotech from Kali, Inc.. | CI |
2020 | PAO Group, Inc. agreed to acquire NCM Biotech from Kali, Inc.. | CI |
Business Summary
Number of employees: 171
Sales per Business
USD in Million | 2017 | Weight | 2018 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceuticals
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -3.44% |
Sales per region
USD in Million | 2017 | Weight | 2018 | Weight | Delta |
---|---|---|---|---|---|
China
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -3.44% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Frederick Ferri
CEO | Chief Executive Officer | - | 18-12-18 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 285,133,954 | 282,282,614 ( 99.00 %) | 0 | 98.86 % |
Stock B | 0 | 394,478 | 0 | 0 |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
-.--% | 1.54K | |
+48.39% | 779B | |
-6.13% | 354B | |
+20.61% | 333B | |
+10.00% | 301B | |
+19.16% | 249B | |
-1.88% | 216B | |
+11.62% | 214B | |
+5.80% | 163B | |
-2.50% | 159B |
- Stock Market
- Equities
- KALY Stock
- Company Kali, Inc.